A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors

Journal of Neurology

Volumn 247, Issue 4, 2000, Pages 297-302

  Streffer, Johannes ^a   Schabet, Martin ^a   Bamberg, Michael ^b   Grote, Ernst H ^b   Meyermann, Richard ^a   Voigt, Karsten ^b   Dichgans, Johannes ^a   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Brain tumor; Chemotherapy; Oligoastrocytoma; Oligodendroglioma; PCV

Indexed keywords

LOMUSTINE; ONDANSETRON; PROCARBAZINE; TROPISETRON; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TREATMENT PLANNING; VOMITING;

EID: 0033997675     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050587     Document Type: Article

References (28)

1. 1. Allison RR, Schulsinger A, Vongtama V, Barry T, Shin KH (1997) Radiation and chemotherapy improve outcome in oligodendroglioma. Int J Radiat Oncol Biol Phys 37:399-403
2. 2.Bullard DE, Rawlings CE III, Phillips B, Cox EB, Schold SC, Burger P, Halperin EC (1987) Oligodendroglioma. An analysis of the value of radiation therapy. Cancer 60:2179-2188
3. 3. Cairncross JG, Macdonald DR (1988) Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23:360-364
4. 4. Cairncross JG, Macdonald DR, Ramsay DA (1991) Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 31:78-82
5. 5. Cairncross JG, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C, Wainman N, Eisenhauer E, for the National Cancer Institute of Canada Clinical Trials Group (1994) Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12:2013-2021
6. 6. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479
7. 7. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A (1994) Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 35:1018-1034
8. 8. Chamberlain MC, Kormanik PA (1997) Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas. J Clin Oncol 15:3427-3432
9. 9. Chen R, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. J Neurosurg 83: 724-728
10. 10. Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM, Curran W (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of radiation therapy oncology group 83-02. Int J Radiat Oncol Biol Phys 38:911-914
11. 11. Fulton D, Urtasun R, Forsyth P (1996) Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neurooncol 27:149-155
12. 12. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS (1994) The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 30:567-573
13. 13. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B (1992) The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 76:741-745
14. 14. Hondre S, Chinot O, Dufour H, Bouillaut P, Braguer D, Grisou F (1998) Temodal (temozolomide) in nitrosoureas pre-treated malignant glioma patients. Single institute study. J Neurooncol 39 [Suppl]:151
15. 15. Kim L, Hochberg FH, Thornton AF, Harsh iv GR, Patel H, Finkelstein D, Louis DN (1996) Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 85:602-607
16. 16. Kirby S, Macdonald D, Fisher B, Gaspar L, Cairncross G (1996) Pre-radiation chemotherapy for malignant glioma in adults. Can J Neurol Sci 23: 123-127
17. 17. Kros JM, Pieterman H, van Eden CG, Avezaat CJ (1994) Oligodendroglioma: the Rotterdam-Dijkzigt experience. Neurosurgery 34:959-966
18. 18. Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA (1993) The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-370
19. 19. Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
20. 20. Mason WP, Krol GS, DeAngelis LM (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46:203-207
21. 21. Paleologus NA, Macdonald DR, Vick NA, Cairncross JG (1999) Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology 53:1141-1143
22. 22. Peterson K, Paleologos N, Forsyth P, Macdonald DR, Cairncross JG (1996) Salvage chemotherapy for oligodendroglioma. J Neurosurg 85:597-601
23. 23. Poisson M, Stragliotto G, Davila G, Duyckaerts C, Delattre JY (1995) [Gliomatous meningitis of hemispheric tumors. Study of 22 cases in adults]. Rev Neurol (Paris) 151:177-189 (in French)
24. 24. Schiffer D, Dutto A, Cavalla P, Bosone I, Chio A, Villani R, Bellotti C (1997) Prognostic factors in oligodendroglioma. Can J Neurol Sci 24:313-319
25. 25. Soffietti R, Ruda R, Bradac GB, Schiffer D (1998) PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 43: 1066-1073
26. 26. Van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, Van Groeningen CJ, Krouwer HGJ, Taphoorn MJB, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJA, Boogerd W, for the Durch Neuro-Oncology Group (1998) Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurology 5: 1140-1145
27. 27. Van den Bent MJ, Pronk L, Sillevis Smitt PAE, Eskens FALM, Vecht CJ, Verweij J (1998) Temozolomide in recurrent oligodendroglioma after PCV chemotherapy. J Neurooncol 39 [Suppl]:151
28. 28. Wallner KE, Gonzales M, Sheline GE (1988) Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68:684-688